(CCEP) Coca-Cola European Partners - Overview
Stock: Soft Drinks, Water, Juice, Energy Drinks, Tea
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.61% |
| Yield on Cost 5y | 5.33% |
| Yield CAGR 5y | 9.56% |
| Payout Consistency | 90.3% |
| Payout Ratio | 117.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.6% |
| Relative Tail Risk | -3.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 20.49 |
| Character TTM | |
|---|---|
| Beta | 0.171 |
| Beta Downside | 0.374 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.35% |
| CAGR/Max DD | 1.75 |
Description: CCEP Coca-Cola European Partners January 29, 2026
Coca-Cola Europacific Partners PLC (NASDAQ: CCEP) is the largest independent bottler of Coca-Cola products in Europe and the Asia-Pacific, manufacturing, distributing and selling a broad portfolio of non-alcoholic ready-to-drink beverages-including carbonated soft drinks, water, sports drinks, teas, coffees, juices, energy drinks and RTD alcoholic mixers-under iconic brands such as Coca-Cola Original Taste, Zero Sugar, Sprite, Fanta, Monster Energy, Schweppes, and many regional labels.
In its most recent FY 2025 filing (released Feb 2026), CCEP reported net sales of **$27.2 billion**, a **3.1 % volume increase** on a constant-currency basis, and an **operating margin of 18.5 %**. Free cash flow rose to **$2.8 billion**, supporting a **net-debt-to-EBITDA ratio of 2.2 x**, down from 2.5 x a year earlier. The company also disclosed that **PET-resin and aluminum commodity prices fell 7 % YoY in Q4 2025**, boosting packaging cost efficiency, while its **2025 sustainability program delivered a 12 % reduction in carbon intensity per liter** versus 2022 levels.
Key economic and sector drivers that could affect CCEP’s outlook include: (1) **inflation-adjusted consumer demand for low-sugar and functional beverages**, which has been growing at a 4-5 % CAGR globally according to Euromonitor; (2) **exchange-rate volatility**, particularly the EUR/GBP and EUR/USD pairs, which can materially impact reported earnings; and (3) **regulatory pressure on single-use plastics**, prompting continued investment in recyclable packaging and circular-economy initiatives. These factors introduce both upside potential from premium-segment expansion and downside risk from cost-pass-through constraints.
For a deeper quantitative assessment, the ValueRay platform provides a granular, forward-looking model of CCEP’s cash-flow dynamics.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 3.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 8.38 > 1.0 |
| NWC/Revenue: -4.02% < 20% (prev -4.84%; Δ 0.82% < -1%) |
| CFO/TA 0.17 > 3% & CFO 5.55b > Net Income 3.15b |
| Net Debt (10.35b) to EBITDA (6.43b): 1.61 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (459.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 35.88% > 18% (prev 0.36%; Δ 3551 % > 0.5%) |
| Asset Turnover: 130.0% > 50% (prev 90.70%; Δ 39.33% > 0%) |
| Interest Coverage Ratio: 11.13 > 6 (EBITDA TTM 6.43b / Interest Expense TTM 438.4m) |
Altman Z'' 2.00
| A: -0.05 (Total Current Assets 8.08b - Total Current Liabilities 9.69b) / Total Assets 31.79b |
| B: 0.28 (Retained Earnings 8.95b / Total Assets 31.79b) |
| C: 0.16 (EBIT TTM 4.88b / Avg Total Assets 30.79b) |
| D: 0.33 (Book Value of Equity 7.72b / Total Liabilities 23.28b) |
| Altman-Z'' Score: 2.00 = BBB |
Beneish M -2.99
| DSRI: 0.75 (Receivables 3.35b/3.02b, Revenue 40.04b/27.03b) |
| GMI: 1.01 (GM 35.88% / 36.21%) |
| AQI: 0.95 (AQ_t 0.55 / AQ_t-1 0.58) |
| SGI: 1.48 (Revenue 40.04b / 27.03b) |
| TATA: -0.08 (NI 3.15b - CFO 5.55b) / TA 31.79b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of CCEP shares?
Over the past week, the price has changed by +6.39%, over one month by +13.83%, over three months by +11.59% and over the past year by +25.00%.
Is CCEP a buy, sell or hold?
- StrongBuy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CCEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 98.4 | 0.8% |
| Analysts Target Price | 98.4 | 0.8% |
| ValueRay Target Price | 120.5 | 23.5% |
CCEP Fundamental Data Overview February 03, 2026
P/E Trailing = 22.925
P/E Forward = 17.8253
P/S = 2.0035
P/B = 4.2795
P/EG = 1.4737
Revenue TTM = 40.04b EUR
EBIT TTM = 4.88b EUR
EBITDA TTM = 6.43b EUR
Long Term Debt = 9.22b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.26b EUR (from shortTermDebt, last quarter)
Debt = 12.01b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.35b EUR (from netDebt column, last quarter)
Enterprise Value = 45.39b EUR (35.44b + Debt 12.01b - CCE 2.06b)
Interest Coverage Ratio = 11.13 (Ebit TTM 4.88b / Interest Expense TTM 438.4m)
EV/FCF = 11.34x (Enterprise Value 45.39b / FCF TTM 4.00b)
FCF Yield = 8.82% (FCF TTM 4.00b / Enterprise Value 45.39b)
FCF Margin = 10.00% (FCF TTM 4.00b / Revenue TTM 40.04b)
Net Margin = 7.86% (Net Income TTM 3.15b / Revenue TTM 40.04b)
Gross Margin = 35.88% ((Revenue TTM 40.04b - Cost of Revenue TTM 25.67b) / Revenue TTM)
Gross Margin QoQ = 35.34% (prev 35.58%)
Tobins Q-Ratio = 1.43 (Enterprise Value 45.39b / Total Assets 31.79b)
Interest Expense / Debt = 0.82% (Interest Expense 98.0m / Debt 12.01b)
Taxrate = 25.63% (323.0m / 1.26b)
NOPAT = 3.63b (EBIT 4.88b * (1 - 25.63%))
Current Ratio = 0.83 (Total Current Assets 8.08b / Total Current Liabilities 9.69b)
Debt / Equity = 1.50 (Debt 12.01b / totalStockholderEquity, last quarter 8.03b)
Debt / EBITDA = 1.61 (Net Debt 10.35b / EBITDA 6.43b)
Debt / FCF = 2.59 (Net Debt 10.35b / FCF TTM 4.00b)
Total Stockholder Equity = 8.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.22% (Net Income 3.15b / Total Assets 31.79b)
RoE = 38.11% (Net Income TTM 3.15b / Total Stockholder Equity 8.25b)
RoCE = 27.93% (EBIT 4.88b / Capital Employed (Equity 8.25b + L.T.Debt 9.22b))
RoIC = 18.83% (NOPAT 3.63b / Invested Capital 19.27b)
WACC = 5.05% (E(35.44b)/V(47.45b) * Re(6.55%) + D(12.01b)/V(47.45b) * Rd(0.82%) * (1-Tc(0.26)))
Discount Rate = 6.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.11%
[DCF Debug] Terminal Value 85.47% ; FCFF base≈2.90b ; Y1≈2.67b ; Y5≈2.40b
Fair Price DCF = 138.0 (EV 72.27b - Net Debt 10.35b = Equity 61.92b / Shares 448.6m; r=5.90% [WACC]; 5y FCF grow -9.98% → 2.90% )
EPS Correlation: -6.99 | EPS CAGR: -46.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 62.29 | Revenue CAGR: 19.15% | SUE: 2.21 | # QB: 1
EPS next Year (2026-12-31): EPS=4.45 | Chg30d=+0.003 | Revisions Net=-1 | Growth EPS=+9.0% | Growth Revenue=+2.6%